Bioprint cells and hydrogels bodily tissue or organ remains in static form and does not have any real added value or complexity like in the human body
R&D Focus
3D Biotissue Analogues
Innovative Solution
BIOFABICS develops: Customizable, 3D Organ-on-Chip Devices for drug discovery and personalized diagnostic/treatment
Solution Effectiveness
BIOFABICS provides R&D services to companies and labswho are looking to employ novel, more accurate, and more reliable tissue/organ models in their own research activities
Investment Funding
Startup Stage
Early Stage
Lead Investors
Startup Braga
People
Founders
Pedro Costa
CEO
Pedro Costa
Awards and Recognitions
Media Apperance
Longevity Technology
Something missing or incorrect on this page? Help us enrich this information
